It is not clear what test he was referring to in his post, and the White House did not immediately return a request for ...

A new study reveals that only about 1 in 3 patients with prostate cancer have a successful first CT simulation, while 1 in 6 need to be rescheduled for another day.

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

Scan.com, a UK-based platform, offers access to private diagnostic scans, including MRI, ultrasound, and CT scans, conducted ...

Liv Hospital integrates PET/CT diagnostics, radionuclide therapies and a multidisciplinary council to create individualized treatment plans for complex cancer and cardiac cases.

Scan.com is a UK-based platform that provides access to private diagnostic scans, including MRI, ultrasound and CT scans, ...

A full-body scan every few years, for some, is a small price to pay for a wide-ranging check-up. Is it the right choice for ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

A new wave of private, preventative health screenings is emerging, and although they might not be able to tell you exactly ...

Instead, he chose to be the first person in Texas to try Inlexzo. Inlexzo is a chemotherapy that comes in a tube that looks ...

Maryland has ushered in some new laws as the calendar changed to 2026 on Thursday, January 1. Meanwhile, the General Assembly ...

PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.